Skip to Content

LL 35 (EndaCof Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg)

Generic Name: guaifenesin/hydrocodone

Pill with imprint LL 35 is White, Capsule-shape and has been identified as EndaCof Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg. It is supplied by Larken Laboratories, Inc..

EndaCof-Tab is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. EndaCof-Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for LL 35

EndaCof Tab

Generic Name:
guaifenesin/hydrocodone
Imprint:
LL 35
Strength:
guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Larken Laboratories, Inc.
National Drug Code (NDC):
54868-5492

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide